Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

Review

Abstract: Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor

Palabras claves:

eGFR, glioma, Humanized, Monoclonal antibody, nimotuzumab, Overall survival, SCCHN

Autores:

Arvind A., Eswaraiah A., Iyer H., Piedra-Sierra P., Ramakrishnan M., Saurez G., Tania Crombet

Fuentes:

scopus